Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Morin

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
EMBO Reports|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Cancers|June 22, 2023
Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic FidelityYuka Takemon, Véronique G LeBlanc, Jungeun Song, et al.
Cell Reports|October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasmsKevin C Yang, Steve E Kalloger, John J Aird, et al.
Cell Reports|February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasmsKevin C Yang, Steve E Kalloger, John J Aird, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Nature|April 1, 2026
Dopaminergic mechanisms of dynamical social specializationC Solié, A Nicolson, R Justo, et al.
Blood|May 8, 2014
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesisTobias Berg, Silvia Thoene, Damian Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast CancerCristiano Ferrario, John Mackey, Karen A Gelmon, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.
EMBO Reports|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Cancers|June 22, 2023
Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic FidelityYuka Takemon, Véronique G LeBlanc, Jungeun Song, et al.
Cell Reports|October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasmsKevin C Yang, Steve E Kalloger, John J Aird, et al.
Cell Reports|February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasmsKevin C Yang, Steve E Kalloger, John J Aird, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Nature|April 1, 2026
Dopaminergic mechanisms of dynamical social specializationC Solié, A Nicolson, R Justo, et al.
Blood|May 8, 2014
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesisTobias Berg, Silvia Thoene, Damian Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast CancerCristiano Ferrario, John Mackey, Karen A Gelmon, et al.
Pageof 25